All Stories

  1. Multiple myeloma cells alter the senescence phenotype of bone marrow mesenchymal stromal cells under participation of the DLK1-DIO3 genomic region
  2. Some aspects of allogeneic stem cell transplantation in patients with myelodysplastic syndrome: advances and controversy
  3. Association between low uric acid levels and acute graft-versus-host disease
  4. Comparative examination of various PCR-based methods for DNMT3A and IDH1/2 mutations identification in acute myeloid leukemia
  5. Bone marrow stromal cells in the pathogenesis of acute myeloid leukemia
  6. JAK2 V617F allele burden quantified by real time quantitative polymerase chain reaction and competitive polymerase chain reaction in patients with chronic myeloproliferative neoplasia
  7. FLT3 Mutations in Early T-Cell Precursor ALL Characterize a Stem Cell Like Leukemia and Imply the Clinical Use of Tyrosine Kinase Inhibitors
  8. Molecular analysis of differentFLT3-ITD mutations in acute myeloid leukemia
  9. Molecular investigation of Ewing sarcoma: about detecting translocations
  10. Bone Marrow Microenvironment in the Pathogenesis of AML
  11. Intrathecal application of donor lymphocytes in leukemic meningeosis after allogeneic stem cell transplantation
  12. Cytogenetic studies in acute leukemia patients relapsing after allogeneic stem cell transplantation
  13. Long-Term Control of HIV by CCR5 Delta32/Delta32 Stem-Cell Transplantation
  14. Successful treatment of partial graft failure after matched unrelated donor stem cell transplantation by a combination of ancestim (stem cell factor) and granulocyte colony stimulating factor in a patient with heavily pre-treated chronic lymphocytic le...
  15. A Novel Method to Quantify and Characterize Leukemia-Reactive Natural Killer Cells in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation following Conventional or Reduced-Dose Conditioning
  16. Chromosomal aberrations in bone marrow mesenchymal stroma cells from patients with myelodysplastic syndrome and acute myeloblastic leukemia
  17. A novel sporadic Burkitt lymphoma cell line (BLUE-1) with a unique t(6;20)(q15;q11.2) rearrangement